Michel de Baar Email & Phone Number
Venture Partner @ Thuja Capital
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Michel de Baar Location
- London, England, GB
Michel de Baar Work
- Venture Partner @ (July 2026 - Present)
- Executive Director, BD and L - Infectious Diseases and Vaccines, CardioMetabolic- and Immunology Diseases @ (September 2016 - July 2026)
- Board Observer @ Themis Bioscience GmbH (October 2019 - June 2020)
- Director, Business Development and Communications @ (September 2015 - September 2016)
- Co-Founder and CBO @ Madam Therapeutics (March 2011 - August 2016)
- Founder and Managing Director @ 2PdB Holdings BV (August 2006 - August 2016)
- Director Business Development @ Top Institute Pharma (November 2013 - August 2015)
- Business and Corporate Development - CrossVax @ (August 2012 - July 2015)
- VP, Business Development @ Crystallics (March 2011 - February 2013)
- VP Business Development @ (July 2010 - March 2011)
- Senior Manager Business Development @ (January 2008 - July 2010)
- Business Development Manager @ (August 2006 - December 2007)
- Senior Scientist and Project Manager and Business Development Manager @ Primagen (April 2000 - August 2006)
- Ph.D. Student @ (January 1996 - January 2000)
- Scientist @ (February 1995 - December 1995)
Michel de Baar Education
- Rotterdam School of Management, Erasmus University
Master of Business Administration (M.B.A.) (Executive MBA)
2009-2010 - Nyenrode Business University
Certificate (Summer Courses and mini-MBA)
2008-2008 - University of Amsterdam
Ph.D. (Medicine)
1996-2000 - Utrecht University
MSc (Medical Biology / Biomedical Sciences)
1991-1995
Michel de Baar Skills
- B2B
- Biochemistry
- Biomarkers
- Biopharmaceuticals
- Biotechnology
- Business Development
- Business Development and Licensing
- Cancer
- Cell
- Cell Biology
- Clinical Development
- Commercialization
- Contract Negotiation
- Diagnostics
- Drug Delivery
- Drug Development
- Drug Discovery
- Due Diligence
- Formulation
- GMP
- Genomics
- Hardware Diagnostics
- Immunology
- Infectious Diseases
- Licensing
- Life Sciences
- Lifesciences
- Market Access
- Mergers & Acquisitions (M&A)
- Molecular Biology
- Negotiation
- Negotiations
- Oncology
- Out-licensing
- Pharmaceutical Industry
- Pharmaceuticals
- Pharmaceutics
- Product Development
- Protein Chemistry
- R&D
- Regulatory Affairs
- Research and Development (R&D)
- Science
- Start-ups
- Strategic Alliances
- Strategy
- Strategy Development
- Technology Transfer
- Vaccines
- Validation
- Development
- CRO
- Chemistry
- Communications
- Sales
- Start Ups
- Medical Devices
- Out Licensing
- Research And Development R&D
- Microsoft Office
- Microsoft Word
- Marketing
- Research
- Public Speaking
- Social Media
- Research and Development
Michel de Baar Summary
- Michel de Baar, based in London, England, GB, is currently a Venture Partner at Thuja Capital. Michel de Baar brings experience from previous roles at MSD, Themis Bioscience GmbH, The Pirbright Institute and Madam Therapeutics. Michel de Baar holds a 2009 - 2010 Master of Business Administration (M.B.A.) in Executive MBA @ Rotterdam School of Management, Erasmus University. With a robust skill set that includes B2B, Biochemistry, Biomarkers, Biopharmaceuticals, Biotechnology and more. Michel de Baar has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Michel de Baar?
Find contact details for 700 million professionals.
Others Named Michel de Baar
Michel de Baar
Projectmanager
Geertruidenberg, NB, NL
Top Thuja Capital Employees
Michel Briejer
Managing Partner
Utrecht, Netherlands
Dieuwertje Toet
Financieel manager
Amsterdam, NH, NL
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co